Lader M
University of London, Department of Psychiatry, UK.
J Neurol. 1997 Apr;244(4 Suppl 1):S18-22. doi: 10.1007/BF03160567.
Both published and unpublished data concerning the rebound, withdrawal, dependence and abuse potential of zopiclone have been reviewed. As expected for an hypnotic drug of about 5 h elimination half-life, rebound has occasionally been detected but is substantially less frequent than with equivalent benzodiazepines. Tolerance to zopiclone does not occur regularly and cross-tolerance to the benzodiazepines may help in a regimen to withdraw from the latter drugs. Dependence on long-term use, as shown by either a characteristic withdrawal syndrome or by psychological craving, is rare considering the world-wide extent of usage. Abuse (addictive non-medical use) is documented but is also rare, in comparison with the widely abused benzodiazepines. It is concluded that zopiclone has substantial advantages over the benzodiazepines in terms of dependence and abuse potential.
已对有关佐匹克隆的反跳、戒断、依赖性和滥用潜力的已发表和未发表数据进行了综述。正如预期的那样,对于一种消除半衰期约为5小时的催眠药物,偶尔会检测到反跳现象,但比等效的苯二氮䓬类药物要少得多。对佐匹克隆的耐受性并不经常出现,对苯二氮䓬类药物的交叉耐受性可能有助于从后者药物中撤药的方案。考虑到全球范围内的使用范围,长期使用导致的依赖性,无论是表现为典型的戒断综合征还是心理渴望,都很少见。与广泛滥用的苯二氮䓬类药物相比,滥用(成瘾性非医疗使用)有记录但也很少见。得出的结论是,在依赖性和滥用潜力方面,佐匹克隆比苯二氮䓬类药物有很大优势。